Related Experiment Video
Updated: Jun 4, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Antibiotic resistance among pathogens causing disease in Jamaican children with HIV/AIDS
P R Byam1, R B Pierre, C D C Christie
1Yale School of Public Health, The University of the West Indies, Kingston 7, Jamaica.
Insights
Antimicrobial resistance is a growing concern in children with HIV/AIDS. This study found that Escherichia coli, a common cause of urinary tract infections and sepsis, is frequently resistant to cotrimoxazole in Jamaican children.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Resistance
- HIV/AIDS Research
Background:
- Limited data exists on antimicrobial resistance patterns in pediatric HIV/AIDS patients from developing nations.
- Urinary tract infections (UTIs) and sepsis are significant causes of morbidity in children with HIV/AIDS.
Purpose of the Study:
- To determine the prevalence and antibiotic susceptibility of bacterial pathogens causing UTIs and sepsis in HIV-infected Jamaican children.
- To assess the impact of antimicrobial resistance on treatment choices in this vulnerable population.
Main Methods:
- A cross-sectional study analyzed clinical and microbiological data from 219 HIV-infected children over five years.
- Infections were defined by CDC criteria, with isolates from urine, blood, and sterile sites considered.
- Prevalence and antibiotic susceptibility patterns of identified bacterial pathogens were analyzed.
Main Results:
- 74 episodes of UTIs and sepsis occurred in 44 patients (20.1%).
- Escherichia coli was the most common UTI isolate (53.8%), while Streptococcus pneumoniae was most frequent in sepsis (36.4%).
- All E. coli isolates from two sites were resistant to cotrimoxazole, with 79.7% of episodes involving cotrimoxazole-resistant organisms in children on prophylaxis.
Conclusions:
- Escherichia coli is the predominant bacterial pathogen causing UTIs and sepsis in this cohort.
- Cotrimoxazole demonstrates poor efficacy as empiric treatment for UTIs and sepsis in HIV-infected children in this setting due to high resistance rates.
Objective:
There are limited data regarding the antimicrobial resistance patterns of pathogens in children with HIV/AIDS from developing countries. We aimed to determine the prevalence and antibiotic susceptibility patterns of bacterial pathogens causing urinary tract infections (UTIs) and sepsis in a cohort of 219 HIV-infected Jamaican children.
Methods:
This cross-sectional study examined clinical and microbiological data for children enrolled in the Kingston Paediatric/Perinatal HIV/AIDS programme from September 1, 2002 to May 31, 2007. Cases were defined as physician-diagnosed, laboratory confirmed UTIs and sepsis based on Centers for Disease Control and Prevention (CDC) criteria. Only isolates from urine, blood and sterile sites were considered.
Results:
Forty-four patients (20.1%) accounted for 74 episodes of UTIs and sepsis. Mean number of infections was 1.7 +/- 1.3 per patient. There were 31 males (70.5%) and mean age at time of infection was 5.6 +/- 4.7 years. Bacterial infections comprised cystitis (n = 52, 70.3%), bacterial pneumonia (n = 15, 20.3%), meningitis (n = 4, 5.4%), septicaemia (n = .2, 2.7%) and bone infection (n = 1, 1.4%). Among 52 UTIs, 39 were caused by a single organism. The most common UTI isolates included Escherichia coli (n = 21, 53.8%) and Enterobacter spp (n = 5, 12.8%). Among 22 cases of sepsis, isolates included Streptococcus pneumoniae (n = 8, 36.4%) and coagulase negative Staphylococcus (n = 6, 27.3%). All E coli isolates at two of three clinical sites were resistant to cotrimoxazole. There were 79.7% (n = 51) of infectious episodes with a cotrimoxazole-resistant organism occurring among those on cotrimoxazole prophylaxis.
Conclusions:
Escherichia coli was the most frequent bacterial isolate. Cotrimoxazole is a poor choice for empiric treatment of sepsis and UTIs in this clinical setting.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Pharmacokinetics in Pediatric Patients: Drug Excretion
Antimicrobial Effectiveness
Antibiotic Selection

